BBIO
$67.25+0.51%
as of close, Oct 2, 2026
☾ AH $67.25 +0.51%
BridgeBio Pharma Inc.Stock · Health CareNasdaq Composite 0.03%US Stock Market 0.02%Russell 1000 0.02%Russell 3000 0.02%
BBIO financial statements
The full income statement, balance sheet, and cash-flow statement for BridgeBio Pharma Inc. (BBIO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 188.0M2024-09 189.0M2024-12 190.2M2025-03 189.9M2025-06 191.2M2025-09 192.7M2025-12 193.9M2026-03 195.9M2026-06 195.5M+4.0% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 502M+126.3% | 222M+2285.3% | 9.30M-88.0% | 77.6M+11.4% | 69.7M+745.1% | |
| Cost of revenue | 21.0M+440.5% | 3.88M+58.5% | 2.45M-28.8% | 3.43M+10.3% | 3.11M | |
| Research & development | 452M-10.8% | 506M+11.1% | 456M+14.1% | 399M-11.4% | 451M+33.8% | |
| Selling, general & administrative | 531M+83.9% | 289M+91.9% | 151M+5.2% | 143M-25.5% | 192M+31.9% | |
| Restructuring | — | 15.6M+96.9% | 7.93M-81.9% | 43.8M | 0.00 | |
| Amortization of intangibles | 2.70M+12.5% | 2.40M+0.0% | 2.40M+0.0% | 2.40M-7.7% | 2.60M | |
| Operating income | -523M+11.7% | -593M+2.4% | -607M-18.6% | -512M+11.2% | -577M-21.5% | |
| Interest expense | 53.1M-41.6% | 91.0M+11.9% | 81.3M+1.1% | 80.4M+72.0% | 46.8M+27.6% | |
| Interest & investment income | 19.9M+15.1% | 17.2M-4.4% | 18.0M+139.2% | 7.54M+565.7% | 1.13M-71.8% | |
| Other non-operating income | 43.1M+250.9% | 12.3M-29.3% | 17.4M+331.6% | -7.50M-120.9% | 35.8M+2092.4% | |
| Equity-method income | -72.6M-132.8% | -31.2M | 0.00 | 0.00 | — | |
| Gain (loss) on equity securities | 0.00-100.0% | 8.14M-55.6% | 18.3M+322.7% | -8.22M-127.5% | 29.9M | |
| Pre-tax income | -733M-35.1% | -542M+17.0% | -653M-34.8% | -485M | — | |
| Income tax | 435K-62.3% | 1.15M | 0.00 | 0.00 | — | |
| -733M-34.9% | -543M+16.8% | -653M-34.8% | -485M+17.4% | -586M-16.0% | ||
| Net income to non-controlling interest | -8.01M-5.6% | -7.58M+24.5% | -10.0M-189.7% | -3.47M+85.5% | -23.9M+57.9% | |
| Net income to common | -725M-35.3% | -536M+16.7% | -643M-33.7% | -481M+14.5% | -563M-25.4% | |
| -$3.78-31.3% | -$2.88+27.1% | -$3.95-21.2% | -$3.26+16.4% | -$3.90-2.6% | ||
| EPS (basic) | -$3.78-31.3% | -$2.88+27.1% | -$3.95-21.2% | -$3.26+16.4% | -$3.90-2.6% | |
| Weighted-avg shares (basic) | 192M+2.9% | 186M+14.3% | 163M+10.4% | 147M+2.2% | 144M+22.3% | |
| Weighted-avg shares (diluted) | 192M+2.9% | 186M+14.3% | 163M+10.4% | 147M+2.2% | 144M+22.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 798M+10.7% | 721M+50.9% | 478M-13.0% | 549M-38.3% | 889M+38.3% | ||
| Cash & equivalents | 570M-16.3% | 681M+81.2% | 376M-0.2% | 377M-4.3% | 394M+10.6% | |
| Short-term investments | — | 0.00 | 0.00-100.0% | 51.6M-86.9% | 394M+56.9% | |
| Accounts receivable | 139M+2853.1% | 4.72M+169.7% | 1.75M | — | — | |
| Inventory | 26.8M | 0.00 | — | — | — | |
| Prepaid expenses | 44.1M+26.4% | 34.9M+43.5% | 24.3M+10.9% | 21.9M-32.1% | 32.3M-9.7% | |
| 936M+1.8% | 919M+68.3% | 546M-12.3% | 623M-38.5% | 1.01B+43.9% | ||
| Property, plant & equipment | 5.37M-23.5% | 7.01M-40.7% | 11.8M-18.9% | 14.6M-51.5% | 30.1M+47.9% | |
| Operating lease right-of-use | 8.15M+41.3% | 5.77M-28.2% | 8.03M-24.8% | 10.7M-32.9% | 15.9M-3.6% | |
| Intangible assets | 28.1M+17.3% | 23.9M-9.1% | 26.3M-8.3% | 28.7M-36.1% | 44.9M | |
| Other non-current assets | 16.7M-8.2% | 18.2M-19.6% | 22.6M+11.9% | 20.2M-38.8% | 33.0M+38.0% | |
| 288M+86.5% | 154M+7.3% | 144M+18.5% | 121M-10.1% | 135M+41.2% | ||
| Accounts payable | 36.2M+276.7% | 9.62M-9.7% | 10.7M-7.8% | 11.6M-2.7% | 11.9M+32.9% | |
| Deferred revenue | 7.19M-50.8% | 14.6M+139.6% | 6.10M-25.3% | 8.16M | 0.00 | |
| Current lease liability | 6.19M+37.4% | 4.51M+9.2% | 4.13M+12.3% | 3.67M-25.6% | 4.94M+30.1% | |
| Other current liabilities | 120M+263.5% | 33.1M | — | — | — | |
| Finance lease liability (current) | — | — | — | — | 295K+130.5% | |
| 3.01B+26.7% | 2.38B+25.8% | 1.89B+1.1% | 1.87B-0.6% | 1.88B+215.3% | ||
| Long-term debt | 2.01B+359.0% | 437M-2.0% | 446M+3.6% | 431M+0.1% | 431M+366.1% | |
| Deferred revenue (non-current) | 13.1M-23.5% | 17.1M+358.7% | 3.73M | — | — | |
| Non-current lease liability | 3.81M-18.8% | 4.70M-47.7% | 8.98M-26.8% | 12.3M-29.6% | 17.4M+18.7% | |
| Operating lease liability (total) | 10.0M+8.7% | 9.20M-29.8% | 13.1M-17.8% | 15.9M-28.7% | 22.4M+21.1% | |
| Finance lease liability (total) | — | — | — | — | 1.54M-9.5% | |
| Finance lease liability | — | — | — | — | 1.25M-20.9% | |
| Other non-current liabilities | 244K-14.7% | 286K-94.9% | 5.63M-78.9% | 26.6M+20.7% | 22.1M+131.8% | |
| -2.09B-42.1% | -1.47B-8.4% | -1.35B-7.9% | -1.25B-44.1% | -870M-1603.1% | ||
| Preferred stock | 0.00 | 0.00 | — | — | — | |
| Common stock | 202K+3.1% | 196K+8.3% | 181K+15.3% | 157K+1.9% | 154K+23.2% | |
| Additional paid-in capital | 2.06B+8.1% | 1.90B+28.5% | 1.48B+57.8% | 939M+11.5% | 842M-17.6% | |
| Retained earnings | -3.82B-23.4% | -3.10B-20.9% | -2.56B-33.5% | -1.92B-33.5% | -1.44B-61.7% | |
| Treasury stock | 323M+17.6% | 275M+0.0% | 275M+0.0% | 275M+0.0% | 275M+266.7% | |
| Accumulated other comprehensive income | 12.0K+50.0% | 8.00K-74.2% | 31.0K+109.5% | -328K-148.5% | -132K-168.8% | |
| Non-controlling interest | 10.6M+4.4% | 10.2M-9.7% | 11.2M-0.3% | 11.3M+230.7% | 3.41M-92.9% | |
| Total equity incl. non-controlling | -2.08B-42.4% | -1.46B-8.5% | -1.34B-8.0% | -1.24B-43.4% | -867M-916.0% | |
| Total liabilities & equity | 936M+1.8% | 919M+68.3% | 546M-12.3% | 623M-38.5% | 1.01B+43.9% | |
| Common shares issued | 202M+3.1% | 196M+8.3% | 181M+15.6% | 157M+2.1% | 154M+22.6% | |
| Common shares outstanding | 195M+2.5% | 190M+8.5% | 175M+16.2% | 151M+2.2% | 147M+19.9% | |
| Shares outstanding (cover) | 194M+1.9% | 190M+8.2% | 176M+16.2% | 151M+2.6% | 148M-0.9% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -446M+14.4% | -521M+1.3% | -528M-25.8% | -419M+15.8% | -498M-24.6% | ||
| Depreciation & amortization | 5.43M-10.6% | 6.08M-6.5% | 6.49M-4.1% | 6.77M+15.9% | 5.84M+301.3% | |
| Intangible amortization | 2.70M+12.5% | 2.40M+0.0% | 2.40M+0.0% | 2.40M-7.7% | 2.60M | |
| Share-based compensation | 133M+38.9% | 95.8M-11.9% | 109M+18.7% | 91.6M-8.0% | 99.5M+70.2% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | — | — | |
| Change in receivables | 135M+4434.6% | 2.97M+119.4% | -15.3M-1.0% | -15.2M | — | |
| Change in inventory | 25.3M | 0.00 | 0.00 | — | — | |
| Change in payables | 26.6M+1659.9% | 1.51M-45.6% | 2.78M+896.6% | -349K-112.3% | 2.83M+485.4% | |
| -24.5M-140.3% | 60.8M+12.5% | 54.0M-88.1% | 453M+325.6% | -201M-279.0% | ||
| Capital expenditure | 1.10M+17.6% | 933K-28.6% | 1.31M-72.9% | 4.82M-63.6% | 13.2M+76.2% | |
| Free cash flow | -447M+14.3% | -522M+1.4% | -529M-24.7% | -424M+17.0% | -511M-25.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other investing activities | — | — | — | 0.00 | 0.00-100.0% | |
| 359M-52.0% | 748M+65.8% | 452M+3537.9% | -13.1M-101.8% | 736M+64.7% | ||
| Long-term debt issued | 0.00-100.0% | 450M | 0.00 | 0.00-100.0% | 456M | |
| Long-term debt repaid | 0.00-100.0% | 473M | 0.00-100.0% | 20.5M-83.5% | 124M | |
| Common stock issued | 0.00-100.0% | 315M-30.0% | 450M+9170.6% | 4.85M | 0.00 | |
| Common stock repurchased | 48.3M | 0.00 | 0.00 | 0.00-100.0% | 200M+166.7% | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | — | 0.00 | 0.00-100.0% | 837K | 0.00 | |
| Net change in cash | -111M-138.5% | 289M+1402.4% | -22.2M-208.0% | 20.5M-45.6% | 37.7M+783.0% | |
| Interest paid | 43.7M-52.2% | 91.3M+49.5% | 61.1M+12.2% | 54.4M+82.9% | 29.8M+94.3% | |
| Income taxes paid | 1.20M | 0.00 | 0.00 | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 14.8B+184.1% | 5.22B-25.7% | 7.02B+516.6% | 1.14B-53.7% | 2.46B-76.8% | |
| P/S | 29.5×+25.6% | 23.5×-96.8% | 744.9×+5698.4% | 12.8×-63.6% | 35.3×-97.2% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: BBIO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BBIO filings on SEC EDGAR → Not investment advice.